CHAPTER 1: The Liability Waiver at Midnight
Part 1
“Sign the clinical trial liability waiver, Nora, or I will revoke your nursing license before the night shift ends,” my former mentor, Chief of Medicine Professor Arthur Kingsley, whispered as he handed me the fatal overdose reports for Patient 402.
He spent seventeen years convincing me I was an uneducated orphan he had saved from poverty, using my loyalty to hide his catastrophic trial failures.
Tonight, he forced me into the isolation ward to take sole legal responsibility for A$14.2 million in illegal drug trial deaths.
He thought I would break under the threat of losing my thirty-year career.
He had no idea who was waiting inside that ward.
The words hung in the stale air of the Clinical Trial Unit, heavy and cold. My hand, steady after thirty years of holding IV lines, trembled slightly as I took the thin stack of papers.
Professor Kingsley’s eyes, usually so sharp and commanding, were shadowed in the dim corridor.
The fluorescent lights above hummed, casting long, unsettling shadows down the deserted hall of St. Jude’s Public Hospital. It was just past midnight, and the usual bustle of the oncology ward had quieted to an eerie hush.
Only the rhythmic beep of monitors from behind closed doors offered any sign of life.
“Walk with me, Nora,” Kingsley murmured, his voice a low, gravelly command.
He didn’t wait for a reply, simply turned and strode towards the Isolation Wing. His crisp white lab coat, freshly pressed, seemed to glow faintly in the subdued light, a stark contrast to my practical navy scrubs.
I hesitated for a moment, my gaze lingering on the waiver. The title blurred: “Indemnity and Liability Agreement.”
A cold dread coiled in my stomach.
Kingsley glanced back, a flicker of impatience crossing his face.
“Don’t dally, Eleanor. We haven’t got all night.” He rarely used my full name. It was always “Nora,” an affectionate familiarity that now felt like a brand, a mark of his ownership.
I smoothed the papers against my thigh, the clinical language already a warning. Every instinct screamed at me to turn and run, to find Dr. Croft, the TGA auditor who had been asking questions all week. But Kingsley had been my world.
My mentor. My protector.
I followed him, the soft squeak of my rubber-soled shoes echoing in the silence. The isolation wing was kept at negative pressure, a sterile bubble designed to contain airborne pathogens, but tonight, it felt like a trap.
He pushed open the heavy, sealed door to Isolation Room 4. The room was dark, the patient having been moved to the morgue hours ago. A single security camera, usually a benign presence, blinked red in the upper corner, watching.
Kingsley gestured towards the small, plastic-topped table in the corner. A ballpoint pen lay beside a stack of forms.
“Sit,” he ordered, not unkindly, but with an underlying steel that brooked no argument.
I sank onto the uncomfortable stool, the silence of the room amplifying the thump of my own heartbeat. My gaze drifted to the empty bed, stripped of its linens. Patient 402. A young father of two, gone too soon.
Kingsley leaned against the doorway, blocking the exit. He folded his arms, watching me.
“You’ve seen the reports, Nora. Fatal cardiac arrest. Anaphylactic shock from Trial-99. It’s an unfortunate incident, but these things happen in advanced trials.”
He paused, letting the words hang.
“We need to close this out cleanly. For the hospital. For the new Pacific Health Corp grant.”
I looked down at the waiver again. My name, Eleanor Finch, typed neatly at the bottom. The blank space for my signature stared back, demanding accountability.
A tremor went through me. Thirty years. Every single one of them dedicated to St. Jude’s, to these patients. To *him*.
I began to read, line by line, my professional eye scanning for details. It was standard legal boilerplate at first, until I reached clause 7.
“The undersigned, Eleanor Finch, acknowledges full and sole responsibility for the administration of the Trial-99 immunotherapy protocol to Patient 402 (MRN 88-345-02) on 23rd October at 23:47.”
My brow furrowed. 23:47. That was my shift, yes. But it wasn’t right.
“What is this?” I asked, my voice barely a whisper. I knew my own protocols. I triple-checked everything.
Kingsley stepped closer, his shadow falling over the document.
“It’s the official record, Nora. Your signature simply confirms the timeline.”
He took a step back, letting me examine the “official record” more closely. On top of the waiver, he had placed a printout of the electronic drug administration log. It was from the hospital’s internal system, dated that night.
My eyes darted across the page. There, beside Patient 402’s name, was the dosage: “200mg.”
A sharp gasp escaped me. My hand flew to my mouth.
“Two hundred milligrams?” I choked out, staring at the number. “That’s… that’s double the approved dosage!”
Kingsley’s face remained impassive. “An error, perhaps, in transcription. Or a miscalculation on the night.”
My gaze, however, was no longer on the main log. Below the 200mg entry, in a smaller, almost hidden annotation, was a secondary approval code. It was a string of characters and numbers, followed by a single, bolded initial: “AK.”
Arthur Kingsley.
My head snapped up. I looked from the “AK” on the log to Kingsley’s calm, almost dismissive expression. My mind reeled. He had personally authorized a lethal double dose. It wasn’t my mistake. It was his.
“You… you ordered this,” I stammered, pointing a shaking finger at the log. “You authorized the double dose. Patient 402 died because of *your* order, Arthur.”
A muscle twitched in Kingsley’s jaw. He reached out, his fingers brushing the edge of the printed log, as if to pull it away.
“Nonsense, Nora. That’s a system glitch, a routing error.”
“A system glitch doesn’t put your initials next to a fatal dosage,” I shot back, my voice gaining strength, the years of silent deference dissolving into a wave of betrayal. “This isn’t my error. This is a deliberate, direct order.”
Before I could say another word, a heavy thud echoed from the corridor. The sealed door, previously ajar, swung shut with a muffled clang.
A distinct click followed, the sound of a locking mechanism engaging.
Kingsley spun around, his face suddenly taut with alarm.
Through the reinforced glass panel of the isolation door, a figure in a dark suit was visible, his expression grim. Dr. Julian Croft, the TGA Lead Medical Investigator.
He held a key card in his hand, his eyes fixed on Kingsley.
Then, his gaze shifted, meeting mine through the glass.
“Dr. Eleanor Marian Finch,” Croft’s voice boomed, amplified through the ward’s intercom system, “this ward is now under federal audit lock. No one leaves.”
Part 2
My thoughts raced. *Dr. Eleanor Marian Finch?* My mother’s name. Marian. Only Kingsley ever called me Eleanor, and only then when he was angry. But Dr. Julian Croft? He was the federal auditor, here to investigate trial irregularities, not to use my mother’s full research title. My heart pounded against my ribs.
I stared at him through the glass. He wasn’t looking at Kingsley. He was looking at *me*.
Kingsley, however, was in a frenzy. He began banging on the locked door, shouting through the reinforced glass. “Croft! What do you think you’re doing? This is a hospital, not a federal lock-up! Release this ward immediately!”
Croft ignored him. He took another step closer to the door, his eyes still fixed on me, a strange intensity in their depth. He wasn’t hostile. He wasn’t demanding an arrest. There was something else there, something I couldn’t quite place.
He reached into the inside pocket of his dark suit jacket and pulled out a small, creased photograph. It was old, faded at the edges, and had the distinctive sepia tone of an image from over a decade ago. He held it up against the glass.
It was a picture of a laboratory, filled with old equipment. And in the centre, beaming brightly, was my mother, Marian Finch. Beside her, a much younger version of Julian Croft, barely more than a boy, stood grinning, holding a pipette.
My breath hitched. My mother. She had been gone seventeen years. Kingsley had told me she died in an accident, a tragic loss that left me, an uneducated orphan, dependent on his goodwill.
Croft spoke again, his voice calm but clear through the intercom. “Nora, you are not an orphan, and Professor Kingsley didn’t ‘save’ you from poverty.”
He paused, letting his words sink in, watching my reaction.
“He destroyed your mother’s career, and then he stole her research.”
My mind spun. Stole her research? What was he talking about?
Croft continued, his gaze unwavering. “Dr. Marian Finch discovered the core immunotherapy patent. The very formula Kingsley is now pitching as his own. You, Nora, are the sole rightful owner of that patent. The one he stole seventeen years ago.”
The air left my lungs. The ground beneath me seemed to shift. Everything I thought I knew, every painful memory of my mother’s sudden death, every act of ‘charity’ from Kingsley, crashed down around me.
Kingsley was no longer banging on the door. He had stepped back, his face a mask of shock and fury. He pulled out his phone, already barking orders into it, his eyes darting from Croft to me.
Outside the glass door, Kingsley signalled security to force entry.
CHAPTER 2: The Audit Protocol
The heavy wooden door of Isolation Room 4 rattled once before the lock cracked open.
Three hospital security guards stepped into the room, their boots squeaking against the sterile vinyl floor. Behind them stood Sarah O’Neill, the hospital’s HR Compliance Director, holding a crisp white manila folder against her chest.
“Nora Finch,” Sarah said, her voice sharp and level. “Step away from the medical files immediately.”
She stepped past the guards and placed a document on the stainless steel bedside table. The heading read *NOTICE OF IMMEDIATE SUSPENSION AND GROSS MISCONDUCT*.
“You are suspended effective immediately pending a formal review into the fatal overdose of Patient 402,” Sarah said, adjusting her glasses. “Please surrender your hospital ID badge.”
I picked up the suspension notice. Stapled to the back was a printed copy of the Trial-99 drug administration log.
My eyes ran down the page until they hit the signature line. The timestamp beside the lethal double-dose read 20:15—four hours before my shift had even started. Below it was the digital signature of Chief Registrar Dr. Liam Ross, co-signed under my staff identification number.
“This timestamp is forged,” I said, holding the paper up to the fluorescent light. “Liam wasn’t on the ward at eight o’clock. He was in theatre four until ten.”
“Dr. Ross verified those charts half an hour ago under Professor Kingsley’s direct supervision,” Sarah replied, unblinking. “The system log is absolute.”
Beside me, Dr. Julian Croft stepped forward, placing his hand over the physical chart binder resting on the tray.
“The federal regulatory authority takes precedent over internal hospital HR policy, Ms. O’Neill,” Julian said, pulling a dark blue badge from his jacket pocket. “These charts are now federal evidence under Section 42 of the Therapeutic Goods Act.”
Sarah stared at the blue badge, her rigid posture flinching for the first time. “This is a private hospital administration matter.”
“A patient died of a toxic drug trial reaction twenty minutes ago,” Julian said softly, closing the binder with a firm slap. “This is a homicide investigation.”
CHAPTER 3: Unwitting Accomplices
The doctors’ write-up room on the third floor was quiet except for the hum of the overhead fluorescent tubes.
Dr. Liam Ross sat at a corner workstation, his hands pressed hard against his forehead. His face was gray in the stark lighting.
I pushed the heavy door open and tossed the suspension document onto his keyboard.
“When did you sign this, Liam?” I asked.
Liam jumped, his chair rolling back against the desk. He looked at the paper, then quickly looked away at the blank wall.
“Nora,” he stammered, rubbing his neck. “Professor Kingsley told me it was just an administrative correction. He said the system glitched during the power transfer and lost the dosage timestamps.”
“He put my name on a double-dose chart,” I said, leaning over his desk. “He put a lethal dose of Trial-99 on my nursing record.”
Liam pulled at his surgical collar, his breath coming faster. “He said if we didn’t clean up the chart anomalies before midnight, Pacific Health Corp would withdraw the A$50 million biotech grant. He promised it wouldn’t affect anyone’s registration.”
“He used your digital key to shift the administration time four hours back,” I said. “Right into the window where I was sole nurse on duty.”
Liam stared down at his trembling hands, the color draining entirely from his cheeks.
“I didn’t look at the dose amount,” Liam whispered, his voice cracking. “I just tapped my entry card when he asked me to.”
“Then you better help me pull the raw pharmacy release receipts,” I said. “Before the automated server wipe at midnight.”
CHAPTER 4: A Slip of the Tongue
The basement dispensary smelled of rubbing alcohol and chilled glass.
Chief Pharmacist Dr. Gavin Walsh stood behind the heavy steel counter, tapping rapidly on his terminal keyboard. He looked up, his eyes widening as Liam and I approached the glass partition.
“We need the physical release logs for Trial-99, Batch 4,” Liam said, his voice stronger now. “The midnight automated clearing is in twenty minutes.”
Walsh pulled his hands away from the keyboard as if the keys had burned him. “Those files are restricted to department heads. Professor Kingsley explicitly froze the local server access for all research stock.”
“I am the lead clinical trial nurse for this study,” I said, resting my hands flat on the stainless steel counter. “And Patient 402 is dead.”
Walsh swallowed hard, his neck flushing red above his white lab coat. He glanced nervously at the security camera mounted above the door.
“Look, Nora,” Walsh said, dropping his voice to a whisper. “I don’t have anything to do with the trial dosages. I only followed standard procedure by clearing the 2007 Marian Finch protocol files off the local server, just like Arthur asked.”
The room went dead silent.
Liam froze beside me, turning his head slowly toward the pharmacist. “What did you just say?”
Walsh blinked, his lips remaining parted as the realization of what he had just blurted out hit him.
“The 2007 files,” I said, my heart pounding against my ribs. “He made you delete my mother’s baseline safety logs.”
CHAPTER 5: The Locked Server
Dr. Walsh’s hands began to shake violently. He reached forward and slammed his hand onto the red emergency power switch on the side of his terminal.
“Out,” Walsh gasped, scrambling backward toward the drug vault door. “You shouldn’t be down here. The audit isn’t authorized!”
“Move, Gavin,” Liam commanded, vaulting over the low swinging door of the reception counter.
Liam lunged toward the terminal, jamming his blue registrar override card into the side reader before the screen could go dark. The monitor flickered, displaying a progress bar showing an active file deletion in progress.
Julian Croft stepped through the basement doorway, carrying a black ruggedized laptop. He plugged a thick data cable directly into the terminal’s open diagnostic port.
“Accessing main array,” Julian said calmly, typing rapidly with one hand while holding a thumb drive in the other. “The raw dispatch logs are still cached in the local buffer.”
A series of yellow lines crossed the screen.
“Here it is,” Julian said, pointing at a line of code. “Patient 402 was dispatched a 200mg dosage of Trial-99 at 19:45. The human safety threshold approved by the ethics committee was 100mg.”
“Kingsley doubled it intentionally,” Liam breathed, staring at the number. “To speed up the cellular response markers before the grant deadline.”
Suddenly, the overhead fluorescent lights flickered once and killed out entirely.
The hum of the basement air conditioning died away, leaving only the high-pitched whine of the emergency backup generator upstairs.
CHAPTER 6: Stepping into the Dark
The emergency phone screen illuminated Julian’s face in stark white light.
“They pulled the floor breaker from the main distribution panel upstairs,” Julian said, sweeping the beam of light across the darkened pharmacy aisles. “Kingsley knows we are in the building.”
“The main lifts will be grounded,” I said, picking up a heavy metallic torch from behind the counter. “We take the service shaft behind the linen chute.”
We moved quickly through the dark, narrow service corridor, our footsteps echoing against the concrete walls.
“Why would Kingsley double the dosage if he knew the safety threshold?” Liam asked, ducking under an exposed steam pipe as we reached the elevator service doors.
“Because the commercial formula is flawed,” Julian said, guiding us into the concrete stairwell. “Kingsley’s team removed the stabilizing biological markers from the original 2007 patent to cut production costs by A$3.2 million per commercial batch.”
Julian turned his flashlight down the stairwell, revealing four flights of dark concrete stairs leading down into the deeper sub-basement archives.
“Without those baseline markers,” Julian continued, “the drug causes massive, irreversible vascular collapse in fifteen percent of patients. Kingsley needed to prove the higher dose worked before Pacific Health Corp ran their independent biological assays tomorrow morning.”
“My mother built those stabilizing markers,” I said quietly, gripping the cold handrail.
“Yes,” Julian said. “And Arthur Kingsley spent seventeen years making sure no one ever found the master key.”
CHAPTER 7: The Unbroken Ledger
The sub-basement archive smelled of damp concrete and thirty years of degrading paper.
At the back of the lowest storage bay stood a row of green metal lockers from the 1990s. I pulled a small brass key from inside my uniform collar—a key I had carried every day since my mother’s memorial service in 2007.
The lock turned with a dry metallic click.
Inside the locker sat a dusty, black leather-bound binder with the hand-written title *ST. JUDE’S ONCOLOGY RESEARCH LOG – 2007*.
I opened the binder on top of a stack of storage boxes. Julian held his phone light steady over the yellowed pages.
Page after page was filled with my mother’s precise, narrow handwriting, detailing the exact biological sequence required to stabilize the Trial-99 compound.
“Look at the margin note on page forty,” Julian said, his finger stopping on a red ink annotation.
The note read: *Removing the peptide binder will cause fatal systemic toxicity. Formula must never be produced without Marker-7B.*
“Marker-7B is the exact component Kingsley stripped out of the commercial batch to save money,” Liam said, reading over my shoulder. “It’s all right here. The original safety data was never lost—it was hidden.”
“Not hidden,” I said, turning the ledger over to reveal the final signature page. “Stolen.”
CHAPTER 8: The Registrar’s Choice
We stepped out of the archive stairwell onto the ground floor executive hallway, only to find three men waiting in the dim light.
Professor Arthur Kingsley stood in the center of the corridor, flanked by the hospital’s senior legal counsel and two uniformed security officers.
“That’s far enough, Nora,” Kingsley said, his voice echoed smoothly down the empty hallway. “You’re trespassing on hospital property while under disciplinary suspension.”
He looked past me, fixing his sharp blue eyes directly on Liam.
“Liam,” Kingsley said, stepping forward with his hands comfortably in his coat pockets. “Step away from them. The Board has just approved your immediate appointment as Head of Surgical Oncology, effective at 8:00 AM.”
Liam froze, his hands tightening around the straps of his medical bag.
“All you need to do,” Kingsley continued gently, “is hand over that encrypted drive from Dr. Croft and sign an affidavit confirming Nurse Finch tampered with the medication cart during her shift.”
Kingsley extended an open hand toward the young doctor. “Don’t ruin your career before it even begins for the sake of an aging nurse who belongs in the past.”
Liam looked at Kingsley’s outstretched hand, then back at me. He took a slow, deep breath, reaching into his white coat pocket.
He pulled out his mobile phone, tapped the glass screen, and hit play.
*“The system glitched during the power transfer, Liam,”* Kingsley’s recorded voice blared clearly out of the phone speaker. *“Sign the altered timestamp override now, or your fellowship is terminated before sunrise.”*
Kingsley’s smile vanished instantly. His outstretched hand dropped to his side.
CHAPTER 9: The Emergency Board Hearing
By 2:00 AM, the lights inside St. Jude’s main administrative auditorium were blindingly bright.
At the front of the stepped room, seven members of the hospital executive board sat behind a long curved desk. A large video screen on the back wall displayed a live feed from the boardrooms of Pacific Health Corp in Tokyo and San Francisco.
Professor Arthur Kingsley sat at the witness table, his navy suit pristine, his expression cool and composed.
“This entire late-night spectacle is nothing more than the panicked actions of a bitter, retiring nurse,” Kingsley said into his microphone, addressing the board. “Nurse Finch is facing immediate termination for a catastrophic medication error that cost a trial patient his life.”
Beside him, the hospital’s legal representative nodded in agreement.
“We are forty minutes away from finalizing a A$50 million research partnership,” Kingsley continued, pointing toward the video screen. “A grant that will fund this hospital’s oncology wing for the next decade. I urge the board to dismiss these wild fabrications and clear the room.”
At the rear of the auditorium, the heavy double doors swung open.
TGA Chair Dr. Evelyn Zhang walked down the central aisle, holding a thick stack of printed audit logs. Julian Croft and Liam Ross walked right behind her.
“The Therapeutic Goods Administration has assumed regulatory authority over this facility,” Dr. Zhang announced, her voice ringing clearly through the acoustics of the hall. “No contracts will be signed tonight.”
CHAPTER 10: The Gathering Storm
A wave of low murmurs swept through the public gallery behind us. Word of the midnight audit had spread across the night shift, and dozens of off-duty nurses, registrars, and orderlies were crowding into the back of the auditorium.
On the video screen, the senior Vice President of Pacific Health Corp leaned toward his camera, his eyebrows drawn tight.
“Professor Kingsley,” the executive said through the wall speakers. “Our final funding wire of A$50 million is scheduled for dispatch at 2:30 AM. What is the meaning of this intervention?”
Kingsley stood up from his chair, sweeping his arm toward the back of the room.
“It is a minor administrative dispute, gentlemen,” Kingsley said smoothly, his tone rich with confidence. “The TGA is performing a routine, unannounced inquiry based on unverified allegations. Without a formal judicial court order, this board has full operational authority to proceed with our agreement.”
He turned to face the board members seated at the elevated table.
“Look at our balance sheet,” Kingsley urged them, tapping his finger against the wood. “If we do not secure this grant tonight, St. Jude’s faces an immediate operational deficit. We cannot pay our clinical staff next week. We cannot keep the research wards open.”
Sarah O’Neill stood near the aisle, holding her HR folders tight against her chest, her face pale as she realized the true scale of what was happening.
Kingsley rested his hands flat on the desk, staring down Dr. Zhang. “We sign the papers, or this hospital collapses.”
CHAPTER 11: The Reckoning Read Aloud
Dr. Evelyn Zhang did not sit down. She stepped directly up to the center podium, adjusted her reading glasses, and opened the verified audit folder.
“On October 14th, 2007,” Dr. Zhang read aloud, her voice unhurried and clear, “Dr. Marian Finch submitted baseline safety parameters for the compound now known as Trial-99.”
Kingsley shifted his weight, his eyes darkening. “That historical data is entirely irrelevant to—”
“Silence, Professor Kingsley,” Dr. Zhang cut in without looking up. “The audit trail shows that on November 2nd, 2007, Professor Arthur Kingsley manually purged Dr. Finch’s safety protocols from the hospital mainframes, four days after her death.”
A sharp collective gasp rose from the nurses standing at the back of the room.
“Furthermore,” Dr. Zhang continued, turning a page, “pharmacy dispatch records verified tonight prove that over the past six months, Professor Kingsley personally authorized elevated, untested drug dosages for twelve consecutive trial patients.”
On the wall screen, the Tokyo and San Francisco executives leaned back from their camera feeds, conferring urgently with their legal counsel in muted whispers.
“The clinical trial records were altered retroactively using forged nurse credentials,” Dr. Zhang said, laying the final page flat on the podium. “All safety parameters were systematically ignored to artificially inflate efficacy rates for commercial licensing.”
The video screen suddenly unmuted.
“Pacific Health Corp is terminating all contractual discussions effective immediately,” the CEO stated flatly from Tokyo. “The A$50 million grant line is cancelled.”
Before Kingsley could speak, a high-pitched digital chime sounded from the hospital treasurer’s tablet on the main board desk.
“The primary credit facility,” the treasurer whispered, staring at his screen in shock. “The bank just issued an automated credit line freeze due to regulatory breach. All institutional accounts are locked.”
CHAPTER 12: Systemic Collapse
There were no police sirens in the courtyard. No officers stepped into the room with handcuffs or dramatic warrants.
Instead, the silent, relentless gears of institutional collapse simply took over.
Within three minutes of the credit line freeze, the video screens went black as the international representatives disconnected.
The hospital board members were already standing up from their high-backed chairs, hurriedly packing their leather briefcases without making eye contact with Kingsley.
“Arthur,” the Board Chairman said, his voice flat and distant as he straightened his papers. “Your executive access codes have been revoked. Do not enter the administration wing tomorrow.”
“You can’t do this,” Kingsley said, his voice suddenly thin and hollow in the vast room. “The trial was eighty percent successful! We were weeks away from a global commercial launch!”
No one answered him.
The board members filed out through the side exit alongside their legal teams, eager to put distance between themselves and the impending insolvency liabilities.
Sarah O’Neill stood frozen by the doorway, dropping her HR compliance folders onto an empty chair before quietly slipping out into the corridor.
Liam Ross walked up to Kingsley’s table, detached his clinical keycard from his coat, and laid it quietly beside Kingsley’s motionless hand.
Kingsley sat down slowly in his big leather chair, staring at the empty wooden desks around him. The vast, multimillion-dollar empire he had spent seventeen years constructing had stripped down to an empty room in less than twenty minutes.
CHAPTER 13: Midnight Shift at Triage
It was 3:15 AM on the exact same night when I walked through the double automatic glass doors of St. Jude’s Emergency Department.
Outside, the red and blue emergency lights of three arriving ambulances flashed against the wet concrete drive.
Inside the triage hall, the air was cold and filled with the familiar chaos of a Friday night shift—screaming children, rhythmic heart monitor alarms, and the sharp smell of antiseptic spray.
The clinical trial unit upstairs was dark and sealed shut, but down here on the ground floor, the work had never stopped.
I walked behind the high triage counter, pulled my white coat back over my shoulders, and picked up a yellow plastic clipboard from the stack.
A young junior nurse turned toward me, her eyes wide with panic as she tried to answer three ringing phone lines at once.
“Nora!” she gasped, wiping a strand of hair from her face. “Is it true? Did the hospital lose all its funding? Are they going to close the doors by morning?”
I took the ringing receiver from her hand, set it gently back on its cradle, and picked up a pen.
“The doors aren’t closing,” I said smoothly, checking the vital signs chart on the top sheet of my clipboard. “Bed four needs an IV line, and ambulance two is pulling into the bay right now.”
I adjusted my badge on my collar, stepped around the counter, and walked straight toward the emergency bay doors.
The titles and grants vanished into thin air, but the monitors kept beep-beeping in the dark. In the end, the medicine doesn’t care who owns the building—it only cares who stays by the bed.
Leave a Reply